We were able to detect 100% of recurrences by ctDNA ahead of clinical recurrence, which included all lung metastases as well as other distant metastases,” said Emma Titmuss.

AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination.

In patients with multiple myeloma (MM), serum concentration of chitinase 3-like protein-1 (CHI3L1) protein is correlated with disease severity and predicts disease progression, according to research ...

After transformation, survival rates varied by original cancer type, with the poorest prognosis for those transformed from CLL/SLL and from LPL/WM.

Launch prices for self-administered targeted anticancer therapies have grown precipitously,” researchers wrote.